Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of the American College of Cardiology

• Publication date

  2008-05-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jacc.2007.12.052PMID 18452778
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes

  2007cited by this paper
• Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology.

  2007cited by this paper
• Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial.

  2007influential reference
• Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes.

  2007cited by this paper
• Association of prerandomization anticoagulant switching with bleeding in the setting of percutaneous coronary intervention (A REPLACE-2 analysis).

  2007cited by this paper
• Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary Syndromes

  2006cited by this paper
• Switching from Enoxaparin to Bivalirudin in Patients with Acute Coronary Syndromes without ST-segment Elevation who Undergo Percutaneous Coronary Intervention. Results from SWITCH--a multicenter clinical trial.

  2006cited by this paper
• Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibi

  2006cited by this paper
• A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes.

  2006cited by this paper
• Comparison of fondaparinux and enoxaparin in acute coronary syndromes.

  2006cited by this paper
• Bivalirudin for patients with acute coronary syndromes.

  2006cited by this paper
• High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial.

  2005cited by this paper
• Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.

  2004cited by this paper
• Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

  2004cited by this paper
• ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients

  2002cited by this paper
• The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations.

  2000cited by this paper
• Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin.

  1998cited by this paper

• Bivalirudin infusion at standard or low regimen during elective percutaneous coronary intervention in high-risk bleeding patients with acute coronary syndrome: Study protocol for a prospective, single-center, randomized controlled trial.

  2025cites this paper
• Twenty Years of an Institutional Chest Pain Pathway: What’s Come and What’s Yet to Come

  2023cites this paper
• Non‐ST‐Segment Elevation Acute Coronary Syndrome

  2022cites this paper
• Safety and efficacy of switching from unfractionated heparin to bivalirudin during primary percutaneous coronary intervention

  2018cites this paper
• Validation and Comparison of the CRUSADE and ACTION scores to predict the risk of bleeding in patients with acute coronary syndrome without ST segment elevation

  2018cites this paper
• Anticoagulant Therapy for Acute Coronary Syndromes.

  2017cites this paper
• Non‐ST‐Segment Elevation Acute Coronary Syndrome

  2017cites this paper
• Safety, efficiency and cost effectiveness of Bivalirudin: A systematic review

  2017cites this paper
• New Approaches to the Role of Thrombin in Acute Coronary Syndromes: Quo Vadis Bivalirudin, a Direct Thrombin Inhibitor?

  2016cites this paper
• Bivalirudin or unfractionated heparin in patients with acute coronary syndromes managed invasively with and without ST elevation (MATRIX): randomised controlled trial

  2016cites this paper
• [2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)].

  2016cites this paper
• Heparins crossover in percutaneous coronary interventions: a real issue with increasing rate of transradial procedures?

  2015cites this paper
• [2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation].

  2015cites this paper
• The search for optimal anticoagulation therapy in ACS: The gap between clinical trials and current clinical guidelines

  2015cites this paper
• Wytyczne ESC dotyczące postępowania w ostrych zespołach wieńcowych bez przetrwałego uniesienia odcinka ST w 2015 roku Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC) do spraw postępowania w ostrych zespołach wieńcowych bez przetrwałego uniesienia odcinka ST

  2015cites this paper
• Bivalirudin in stable angina and acute coronary syndromes.

  2015cites this paper
• Bivalirudin in the Treatment of Coronary Artery Disease

  2014influential citation
• anticoagulation therapy in patients undergoing percutaneous intervention

  2014cites this paper
• Contemporary anticoagulation therapy in patients undergoing percutaneous intervention

  2014cites this paper
• Current Antithrombotic Therapy in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Interventions.

  2014cites this paper
• Switching from transfemoral to transradial access for PCI: a single-center learning curve over 5 years.

  2014cites this paper
• Bivalirudin in acute coronary syndromes and percutaneous coronary intervention: should we use it?

  2013cites this paper
• Chapter 9 – Non–ST-Segment Elevation Acute Coronary Syndromes

  2013cites this paper
• Dabigatran for periprocedural anticoagulation following radiofrequency ablation for atrial fibrillation: a meta-analysis of observational studies

  2013cites this paper
• Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study.

  2012cites this paper
• ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

  2012cites this paper
• Controlled reperfusion with intravenous bivalirudin and intracoronary abciximab combination therapy in the porcine myocardial infarction model.

  2012cites this paper
• Bivalirudin

  2012cites this paper
• Antithrombotic therapy in patients with acute coronary syndrome and diabetes mellitus

  2012cites this paper
• Anticoagulation in Percutaneous Coronary Intervention

  2012cites this paper
• Invasive management of the acute coronary syndromes

  2012cites this paper
• Drug-drug interactions in cardiovascular catheterizations and interventions.

  2012cites this paper
• Guía de práctica clínica de la ESC para el manejo del síndrome coronario agudo en pacientes sin elevación persistente del segmento ST

  2012cites this paper
• New Zealand 2012 guidelines for the management of non ST-elevation acute coronary syndromes.

  2012cites this paper
• Safety of bivalirudin in patients with coronary artery disease

  2012cites this paper
• Saphenous vein graft percutaneous coronary intervention via radial artery access: safe and effective with reduced hospital length of stay.

  2012cites this paper
• Percutaneous Coronary Intervention

  2012cites this paper
• Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysis.

  2011cites this paper
• Interventional cardiology: Antithrombotic drug and stent choices in primary PCI

  2011cites this paper
• Outcomes following PCI in patients with previous CABG

  2011cites this paper
• Bleeding avoidance strategies. Consensus and controversy.

  2011cites this paper
• The Year in NonST-Segment Elevation Acute Coronary Syndrome

  2011cites this paper
• Management of non-ST-elevation acute coronary syndromes

  2011cites this paper
• 78-year-old man with nausea and chest pain.

  2011cites this paper
• 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

  2011cites this paper
• ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

  2011cites this paper
• Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial.

  2010cites this paper
• Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudy.

  2010cites this paper
• Direct Thrombin Inhibitors in Acute Coronary Syndromes

  2010cites this paper
• Pharmacology in the Cardiac Catheterization Laboratory

  2010cites this paper
• Anticoagulation therapy in acute coronary syndromes according to current guidelines

  2010cites this paper
• Part 9: Acute coronary syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.

  2010cites this paper
• Predictors of Outcomes in Medically Treated Patients With Acute Coronary Syndromes After Angiographic Triage: An Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Substudy

  2010cites this paper
• Antithrombotic therapy in patients with coronary artery disease and with type 2 diabetes mellitus

  2010cites this paper
• Practical Strategies for the Management of Anticoagulation Therapy: Unsolved Issues in the Cardiac Catheterization Laboratory

  2010cites this paper
• Routine use of fondaparinux in acute coronary syndromes: a 2-year multicenter experience.

  2010cites this paper
• Minimizing the Risks of Anticoagulants and Platelet Inhibitors

  2010cites this paper
• Antiplatelet and Anticoagulant Therapies in Acute Coronary Syndromes

  2010cites this paper
• Part 9: Acute coronary syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

  2010cites this paper
• Bivalirudin: a review of the pharmacology and clinical application

  2010cites this paper
• Frequency and safety of switching antithrombin therapy at a regional PCI center

  2010cites this paper
• Diabetic specific aspects in antithrombotic therapy in patients with coronary artery disease.

  2010cites this paper
• Use of anticoagulant agents and risk of bleeding among patients admitted with myocardial infarction: a report from the NCDR ACTION Registry--GWTG (National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry--Get With the Guidelines).

  2010cites this paper
• Contemporary Reviews in Interventional Cardiology Anticoagulant Therapy for Percutaneous Coronary Intervention

  2010cites this paper
• Anticoagulation in percutaneous coronary intervention

  2010cites this paper
• Emerging drugs for acute myocardial infarction

  2010cites this paper
• High-shear- and-thrombin-inducible platelet adhesion and aggregation in patients undergoing percutaneous coronary intervention

  2010cites this paper
• Regulation of PAR-1 in patients undergoing percutaneous coronary intervention: effects of unfractionated heparin and bivalirudin.

  2009cites this paper
• The year in interventional cardiology.

  2009cites this paper
• Pharmacological and clinical profile of bivalirudin in the treatment of patients with acute coronary syndrome

  2009cites this paper
• New antithrombotic agents in acute coronary syndromes

  2009cites this paper
• Does ‘SWITCHing’ from heparin to bivalirudin monotherapy result in a bleeding benefit?

  2009cites this paper
• Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention

  2009cites this paper
• Actualización en cardiología intervencionista

  2009cites this paper
• The year in non-ST-segment elevation acute coronary syndrome.

  2009cites this paper
• Strategies to minimize bleeding complications of percutaneous coronary intervention

  2009cites this paper
• Safety and tolerability of hirudins in percutaneous coronary intervention and the risk of Kounis syndrome

  2009cites this paper
• Actualización en cardiología intervencionista

  2009cites this paper
• Updates in the management of patients with acute coronary syndrome

  2009cites this paper
• [Update on interventional cardiology].

  2009cites this paper
• HORIZONS trial: a step forward for primary percutaneous coronary intervention

  2009cites this paper
• Contrast-Induced Acute Kidney Injury.

  2008cites this paper
• IIb or not IIb.

  2008cites this paper
• Table 1, Patient characteristics

  2008cites this paper
• The year in non-ST-segment elevation acute coronary syndrome.

  2008cites this paper
• Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention.

  2008cites this paper
• Updating the chest pain algorithm: incorporating new evidence.

  2008cites this paper
• Vascular Health and Risk Management Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Dovepress Selecting the Optimal Antithrombotic Regimen for Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

  year unknowncites this paper